O	0	10	Evaluation
O	11	13	of
O	14	20	breast
O	21	27	cancer
O	28	32	risk
O	33	43	associated
O	44	48	with
B-intervention	49	52	tea
I-intervention	53	64	consumption
O	65	67	by
B-eligibility	68	78	menopausal
I-eligibility	79	82	and
I-eligibility	83	91	estrogen
I-eligibility	92	100	receptor
I-eligibility	101	107	status
O	108	113	among
B-ethinicity	114	121	Chinese
O	122	127	women
O	128	130	in
B-location	131	135	Hong
I-location	136	140	Kong
O	140	141	.

O	142	154	Experimental
O	155	162	studies
O	163	172	implicate
O	173	176	tea
O	177	180	and
O	181	184	tea
O	185	196	polyphenols
O	197	200	may
O	201	203	be
O	204	214	preventive
O	215	222	against
O	223	229	breast
O	230	236	cancer
O	236	237	,
O	238	241	but
O	242	250	evidence
O	251	255	from
O	256	271	epidemiological
O	272	279	studies
O	280	283	has
O	284	288	been
O	289	301	inconsistent
O	301	302	.

O	303	305	We
O	306	315	conducted
O	316	317	a
O	318	326	hospital
O	326	327	-
O	327	332	based
O	333	337	case
O	337	338	-
O	338	345	control
O	346	351	study
O	352	354	to
O	355	363	evaluate
O	364	367	the
O	368	372	role
O	373	375	of
O	376	379	tea
O	380	390	especially
O	391	396	green
O	397	400	tea
O	401	403	in
O	404	410	breast
O	411	417	cancer
O	418	426	etiology
O	426	427	.

O	428	430	We
O	431	444	consecutively
O	445	454	recruited
B-intervention-participants	455	458	756
O	459	467	incident
O	468	474	breast
O	475	481	cancer
O	482	487	cases
O	488	491	and
B-control-participants	492	495	789
O	496	504	hospital
B-control	505	513	controls
O	514	517	who
O	518	521	had
O	522	531	completed
O	532	543	information
O	544	546	on
O	547	550	tea
O	551	562	consumption
O	562	563	.

O	564	566	We
O	567	577	calculated
O	578	582	odds
O	583	589	ratios
O	590	591	(
O	591	594	ORs
O	594	595	)
O	596	599	for
O	600	603	tea
O	604	615	consumption
O	616	621	using
O	622	635	unconditional
O	636	649	multivariable
O	650	658	logistic
O	659	669	regression
O	669	670	.

O	671	673	We
O	674	681	further
O	682	691	conducted
O	692	702	stratified
O	703	711	analyses
O	712	714	to
O	715	721	assess
O	722	729	whether
O	730	733	the
O	734	740	effect
O	741	743	of
O	744	747	tea
O	748	759	consumption
O	760	766	varied
O	767	769	by
O	770	780	menopausal
O	781	787	status
O	788	791	and
O	792	800	estrogen
O	801	809	receptor
O	810	811	(
O	811	813	ER
O	813	814	)
O	814	815	.

O	816	823	Overall
O	823	824	,
B-iv-bin-abs	825	828	439
O	829	830	(
B-iv-bin-percent	830	832	58
I-iv-bin-percent	832	833	.
I-iv-bin-percent	833	834	1
I-iv-bin-percent	834	835	%
O	835	836	)
O	837	843	breast
O	844	850	cancer
O	851	856	cases
O	857	860	and
B-cv-bin-abs	861	864	434
O	865	866	(
B-cv-bin-percent	866	868	55
I-cv-bin-percent	868	869	.
I-cv-bin-percent	869	870	0
I-cv-bin-percent	870	871	%
O	871	872	)
O	873	881	controls
O	882	890	reported
B-outcome	891	897	habits
I-outcome	898	900	of
I-outcome	901	908	regular
I-outcome	909	912	tea
I-outcome	913	921	drinking
O	921	922	,
O	923	930	showing
O	931	933	an
O	934	942	adjusted
O	943	945	OR
O	946	948	of
O	949	950	1
O	950	951	.
O	951	953	01
O	954	955	(
O	955	957	95
O	957	958	%
O	958	960	CI
O	960	961	:
O	962	963	0
O	963	964	.
O	964	966	78
O	966	967	-
O	967	968	1
O	968	969	.
O	969	971	31
O	971	972	)
O	973	976	and
O	977	978	1
O	978	979	.
O	979	981	20
O	982	983	(
O	983	985	95
O	985	986	%
O	986	988	CI
O	988	989	:
O	990	991	0
O	991	992	.
O	992	994	80
O	994	995	-
O	995	996	1
O	996	997	.
O	997	999	78
O	999	1000	)
O	1001	1004	for
O	1005	1008	any
O	1009	1012	tea
O	1013	1016	and
O	1017	1022	green
O	1023	1026	tea
O	1027	1035	drinking
O	1035	1036	,
O	1037	1049	respectively
O	1049	1050	.

O	1051	1058	Regular
O	1059	1062	tea
O	1063	1071	drinking
O	1072	1075	was
O	1076	1089	significantly
O	1090	1100	associated
O	1101	1105	with
O	1106	1107	a
O	1108	1113	lower
B-outcome	1114	1118	risk
I-outcome	1119	1122	for
I-outcome	1123	1129	breast
I-outcome	1130	1136	cancer
I-outcome	1137	1139	in
I-outcome	1140	1143	pre
I-outcome	1143	1144	-
I-outcome	1144	1154	menopausal
I-outcome	1155	1160	women
O	1161	1162	(
O	1162	1164	OR
O	1164	1165	=
O	1165	1166	0
O	1166	1167	.
O	1167	1169	62
O	1169	1170	,
O	1171	1173	95
O	1173	1174	%
O	1174	1176	CI
O	1176	1177	:
O	1178	1179	0
O	1179	1180	.
O	1180	1182	40
O	1182	1183	-
O	1183	1184	0
O	1184	1185	.
O	1185	1187	97
O	1187	1188	)
O	1189	1192	but
O	1193	1195	an
O	1196	1205	increased
O	1206	1210	risk
B-outcome	1211	1213	in
I-outcome	1214	1218	post
I-outcome	1218	1219	-
I-outcome	1219	1229	menopausal
I-outcome	1230	1235	women
O	1236	1237	(
O	1237	1239	OR
O	1239	1240	=
O	1240	1241	1
O	1241	1242	.
O	1242	1244	40
O	1244	1245	,
O	1246	1248	95
O	1248	1249	%
O	1249	1251	CI
O	1251	1252	:
O	1253	1254	1
O	1254	1255	.
O	1255	1257	00
O	1257	1258	-
O	1258	1259	1
O	1259	1260	.
O	1260	1262	96
O	1262	1263	)
O	1263	1264	.

O	1265	1268	The
B-outcome	1269	1277	positive
I-outcome	1278	1289	association
I-outcome	1290	1295	among
I-outcome	1296	1310	postmenopausal
I-outcome	1311	1316	women
O	1317	1320	was
O	1321	1330	strongest
O	1331	1336	among
O	1337	1339	ER
O	1339	1340	-
O	1340	1348	negative
O	1349	1354	green
O	1355	1358	tea
O	1359	1367	drinkers
O	1368	1369	(
O	1369	1371	OR
O	1371	1372	=
O	1372	1373	2
O	1373	1374	.
O	1374	1376	99
O	1376	1377	,
O	1378	1380	95
O	1380	1381	%
O	1382	1384	CI
O	1384	1385	:
O	1386	1387	1
O	1387	1388	.
O	1388	1390	26
O	1390	1391	-
O	1391	1392	7
O	1392	1393	.
O	1393	1395	11
O	1395	1396	)
O	1396	1397	.

O	1398	1401	Tea
O	1402	1404	or
O	1405	1410	green
O	1411	1414	tea
O	1415	1423	drinking
O	1424	1427	was
O	1428	1431	not
O	1432	1442	associated
O	1443	1447	with
O	1448	1455	overall
O	1456	1462	breast
O	1463	1469	cancer
O	1470	1474	risk
O	1474	1475	,
O	1476	1481	which
O	1482	1485	may
O	1486	1488	be
O	1489	1495	masked
O	1496	1498	by
O	1499	1502	the
O	1503	1515	differential
O	1516	1522	effect
O	1523	1525	in
O	1526	1529	pre
O	1529	1530	-
O	1531	1534	and
O	1535	1539	post
O	1539	1540	-
O	1540	1550	menopausal
O	1551	1556	women
O	1556	1557	.
